Animal Models in Cancer Research Ulli Wagner. November 4, 2010.

Slides:



Advertisements
Similar presentations
Points to Ponder What are three functions of DNA?
Advertisements

Genetic Susceptibility Can we identify cells, individuals or subpopulations that are genetically susceptible to radiation?
Key Area : Genetic Control of Metabolism in Micro-organisms Unit 2: Metabolism and Survival.
Chapter 7 Animal Biotechnology.
18. Transgenic Models. Approaches Used in the Analysis of Mammalian Development Observations during embryogenesis Phenotypic analysis of developmental.
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
Long-Term Follow-Up of Subjects in Gene Transfer Clinical Protocols Vector Classes with Potential for Long-Term Risks Carolyn A. Wilson, Ph.D. Division.
Genetic technology Unit 4 Chapter 13.
Genetic Engineering © 2014 wheresjenny.com Genetic Engineering.
 The direct manipulation of an organisms genome using biotechnology  New DNA is inserted into a host genome  Host organism transcribes and translates.
Transplantation and its use in gene technology by Christopher Schlemm and Ilja Klebanov.
MMHCC Informatics Providing Innovative and Integrative Informatics Solutions Johnita Beasley (SAIC) Dana Zhang (SAIC) Sharon Settnek (SAIC)
A look at the world today Fatimah .R., Inthuja .J. & Gowshia .V.
Chapter 7 Animal Biotechnology. Animals in Research.
Model Systems in Cancer Biology and Cancer Medicine Updated: February 7, 2013 Folder Title: Models.
Modifying Genes How can they be changed? 1. Genetic Engineering Replacing genes for desired traits… ◦ Must know exact location  Gene map (genome project)
 In Canada there are 14 organ donors per 1 million people.  In 2007, 4195 Canadians were waiting for organ transplants and of those 193 people died.
Mouse models in Immunology
Genome-Scale Mutagenesis Introduction Model systems –Yeast –Mouse Implications for science.
Other Intramural Training Opportunities at NCI Scientific DisciplinesProgram Population-based research, environmental & genetic determinants of cancer.
1 Cancer Models Database (caMOD). 2 History  January 2000 – Prototype is presented during the Mouse Models of Human Cancers (MMHCC) Steering Committee.
Cancer Cancer is one of the most common diseases in the developed world: Cancer is one of the most common diseases in the developed world: 1 in 4 deaths.
CaMOD – Cancer Models Database
Why don't they look alike? Heredity What are chromosomes? Instructions for Ms. Parkovnick Blue Eyes Tall.
Chapter 7: Animal Biotechnology Introduction to Biotechnology Fall 2006.
1 LS DAM Overview August 7, 2012 Current Core Team: Ian Fore, D.Phil., NCI CBIIT, Robert Freimuth, Ph.D., Mayo Clinic, Mervi Heiskanen, NCI-CBIIT, Joyce.
Animal models of breast and prostate cancer “Advances in targeting cancer pathways” by Cinbo delegates MEDITERRANEAN SCHOOL OF ONCOLOGY 08 April 2016,
Towards a unified MOD resource: An Overview
Biosafety and Recombinant DNA Technology
Chapter 7: Animal Biotechnology
18. Transgenic Models.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Genetic Susceptibility
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Metabolism and Survival
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Presentation transcript:

Animal Models in Cancer Research Ulli Wagner. November 4, 2010

In the News

Animal Models – different Species Drosophila C. elegans Mouse Rat Other Laboratory Animals Rabbit Zebrafish Hamster Cancer in Other Animals Dog Cat Horse Pig Goat

Types of Animal Models Inbred Mice and Rats Brother & sister matings for > 20 generations Inbred strains are considered isogenic (genetically identical) Different strains harbor different characteristics Tumor Frequency Grid

Types of Animal Models Carcinogen-induced models Exposure to chemicals like DMBA (oral cancer in hamster models, mammary gland cancer in mice) Exposure to radiation (UV light -> skin cancer) Hormones, growth factors, nutritional factors, viruses …

Types of Animal Models Transplantation models Allograft transplantation model Immuno-competent recipient Host and graft have same genetic background Xenograft transplantation models Immuno-incompetent recipient Host = mouse, graft = human Fresh tissue or immortalized cell lines Transplantation location Orthotopic Subcutaneous etc

Types of Animal Models Genetically modified N-ethyl-N-nitrosourea (ENU) mutagenesis Random mutagenesis Transgenic animals Carrying one or more foreign genes Depending on the promoter transgene gets turned on time- and/or tissue- specific Targeted modifications Knock- out mice (p53 knockouts – Li-Fraumeni Syndrome) Conditional knockout mice e.g. using the Cre-lox system Tetracycline-controlled transcriptional activation Level of complexity to modeling

Types of Animal Models Spontaneous Mutations Laboratory animal (genetic screening) Companion animals – share the same environment Cats Dogs

Research uses of Animal Models Increase our knowledge of the biology of normal and malfunctioning cells Improve the efficacy and safety of chemical and non-chemical interventions Identify preventive measures Raise awareness of susceptibility and risks Aid in developing imaging technologies

caMOD The Cancer Models Database Submission—Data extracted from literature by curators or submitted by scientists. Search– Customizes searches or predefined searches. System Function Administration— User management and review of models. caMOD is a web-based resource that provides information about animal models for human cancer to the public research community

History January 2000 Prototype is presented during the Mouse Models of Human Cancers (MMHCC) Steering Committee Meeting MMHCC adopts the Cancer Models Database (caMOD) as one of their initiatives July 2000 NCICB assumes responsibility for caMOD Spring 2001 caMOD 1.0 released (2-tier application) December 2005 caMOD 2.0 released (n-tier application, based on caBIG compliance guidelines) July 2007 caMOD 2.1 achieves Silver compatibility December 2008 caMOD 2.5 released (grid service) September 2009 caMOD 2.5 achieves Silver compatibility June 2010 caMOD released October 2010 caMOD released

Status 6,037 models 5,946 Mouse entries 42 Dog entries 13 Rat entries 10 Rabbit entries 9 Zebrafish entries 6 Hamster entries 5 Horse entries 4 Cat entries 1 Goat entry 1 Sheep entry

The Backbone Model Characteristics = Overview Genetic Description, Carcinogenic Interventions and Transplantation describe in more detail how the model was generated. Other parts describe the results of experiments performed or observations made on this particular strain.

Modularity = Endurance and Flexibility Most parts contain multiple pages Multiple entries per category are possible

What makes caMOD unique? Variety of species Inclusion of transplantation models Inclusion of therapy data Efforts to provide cross-species comparisons of therapeutic results caMOD has been designed, architected and constructed to facilitate interoperability with other systems, following caBIG guidelines. Silver-compatible (Data elements in caDSR, available for reuse) Grid-enabled Use of controlled vocabularies (EVS)

Animal Models - Summary Animal models recapitulate many aspects of the genesis progression clinical course of human cancers They are valuable resources in a variety of basic, translational, clinical, and epidemiological investigations.

More Information eMICE Website: Jax (including MTB) Rat Genome Database (RGD) The Zebrafish Model Organism Database (ZFIN) caMOD NCI’s Comparative Oncology Program (Dogs)

Acknowledgements NCI Juli Klemm, Ph.D Cheryl Marks, Ph.D. MMHCC & all contributors Development team Maki Duncan (5AM Solutions) Sima Pandya (SAIC) Curator Maureen Colbert (SAIC)